Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

340B Spotlight: New study raises questions about whether non-profit hospitals are meeting charity care requirements in Affordable Care Act

By Karyn Schwartz  |    November 19, 2015
New data published in The New England Journal of Medicine shows that many non-profit hospitals are not meeting charity care requirements in the Affordable Care Act. These requirements were...   Read More

340B Spotlight: ICYMI – New study on hospital-physician practice consolidation

By Rachel Licata  |    November 3, 2015
In case you missed it, a recent study in JAMA Internal Medicine, “Association of Financial Integration Between Physicians and Hospitals with Commercial Health Care Prices,” looked at the spending...   Read More

340B Spotlight: Rapid growth of contract pharmacies

By Rebecca Davison  |    October 8, 2015
Last week we covered the basics around contract pharmacies in the 340B program. Today we’re taking a closer look at contract pharmacies as a relatively new source of growth in the program. ...   Read More

340B Spotlight: What are contract pharmacy arrangements?

By Allyson Funk  |    October 1, 2015
We’ve been covering 340B a lot in recent weeks, including areas of needed reform: how discounts work, levels of charity care among 340B hospitals and the relatively high rate of 340B hospitals...   Read More

340B Spotlight: Health Care Costs Rising from Increase in 340B Hospital Acquisitions of Physician Practices

By Rebecca Davison  |    September 24, 2015
An increasingly popular and alarming trend among 340B hospitals is hurting the integrity of the program and driving up health care costs in the system. Many 340B hospitals are rapidly acquiring...   Read More

340B Spotlight: A lack of charity care among 340B hospitals

By Allyson Funk  |    September 17, 2015
We’ve talked before about charity care and the 340B drug discount program. Research  found most 340B hospitals provide little to below average levels of charity care. Why is this important?...   Read More

How 340B discounts work

By Rebecca Davison  |    September 9, 2015
Recognizing the importance of access to prescription medicines, Congress created the 340B program in 1992 to help vulnerable or uninsured patients served by safety net facilities get the medicines...   Read More

340B Mega Guidance

By Allyson Funk  |    September 1, 2015
PhRMA appreciates the Health Resources and Services Administration’s (HRSA) efforts in releasing the 340B mega guidance and is pleased to have an opportunity to comment before the guidance is...   Read More

Who Benefits from the 340B Drug Discount Program?

By Allyson Funk  |    June 10, 2015
The 340B program was created by Congress in 1992 to help vulnerable or uninsured patients gain access to needed prescription medicines, by requiring pharmaceutical manufacturers to provide steep...   Read More

340B Spotlight: A Look at 340B Purchases

By Karyn Schwartz  |    June 3, 2015
If you are familiar with the 340B program, you have probably heard the oft-cited assertion that 340B only represents 2% of pharmaceutical sales.[1] But just because a statistic is widely repeated,...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates